FAP and liver cancer: After deconvolution single cells into the bulk cohort (TCGA-LIHC/CHOL) as well as in tumor-AL paired scRNA-seq samples, a significant increase of FAP+ CAFs ratio in liver cancer samples was observed (Wilcoxon test, P < 0.01; paired t-test, P < 0.05) (Figure S1J).